1. Establish that it is clinically appropriate. A prescriber needs a documented diagnosis that matches what the medication treats. For Ozempic that means type 2 diabetes, usually evidenced by an A1C result or a fasting glucose, and typically a treatment history showing what you have already tried, such as metformin. You will also be screened out if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, both of which are contraindications, or a history of a serious allergic reaction to semaglutide.
2. See a licensed prescriber. That can be your primary care physician, an endocrinologist, or a licensed telehealth clinician in your state. There is no legal route to Ozempic in the United States that does not involve a prescriber. Anything that offers one is either not selling Ozempic or not operating legally.
3. Deal with coverage before you fill. Most commercial plans and Medicare Part D plans cover Ozempic for type 2 diabetes, frequently with a prior authorization. A prior authorization usually asks for your diagnosis code, your A1C, and what you have already tried. Plans generally will not cover Ozempic where it is prescribed for weight loss, because that is not an approved use.
4. Fill it and set up follow-up. Ozempic ships as a multi-dose prefilled pen with separate needles. Dose escalation and monitoring happen over months, not at a single visit, so whoever prescribes it should also be following you.
If your prior authorization is denied
A denial is not the end of the process, and it is often procedural rather than clinical. Find out the actual reason first. Plans issue a denial code and a written explanation, and the common ones are a missing diagnosis code, an A1C that was not attached, or step therapy, meaning the plan wants documented evidence that you tried metformin or another agent first. Two of those three are fixed by sending a document.
Ask your prescriber to file an appeal or a peer-to-peer review. A peer-to-peer is a direct conversation between your prescriber and the plan's medical reviewer, and it resolves a meaningful share of denials that a paper appeal does not.
Price the cash routes in parallel. Appeals take time. Knowing what the manufacturer's self-pay channel and local pharmacy cash prices would cost you means you are choosing between known options rather than waiting on one. If the denial is because the prescription was written for weight loss rather than diabetes, none of this will fix it. That is a substantive coverage exclusion, and the answer is a product whose approved use matches your reason for taking it.
What a legitimate online service looks like
Online prescribing does not change the clinical requirements, only how the visit happens and how the medication reaches you. A legitimate service names the licensed prescriber who will evaluate you. It names the pharmacy. It asks for a real medical history and recent labs, and it is willing to decline. It identifies the medication precisely. And its price is somewhere in the range of the numbers in the next section.
What it does not look like: no prescriber, no questions beyond a checkbox, prices far below every legitimate channel, vague product names, and shipping from outside the United States. FDA has repeatedly warned about counterfeit semaglutide products entering the supply chain, some containing the wrong drug entirely. If you are buying a brand-name medication, buy it from somewhere that can tell you which licensed pharmacy dispensed it.
At Society that path starts with a free 2-minute evaluation. Most members hear back from a provider within a day or two, with medication delivered in 1 to 2 days by free and discreet delivery. Prescribing is by licensed US practitioners through US licensed pharmacies, and providers are licensed in the state where the patient is located at the time of consultation, so availability may vary by state.
.png)
.png){kind=avatar}
.webp)
.svg)
.png)
.svg)
.svg)
.png)
